Biography
- Division:
- Division of AIDS, Behavioral and Population Sciences – DABP
- Review Branch:
- Epidemiology and Population Health – EPH
Dr. Ananya Paria is an infectious disease epidemiologist with a scientific background in HIV prevention and clinical research focusing on the therapeutics efficacy of pre-exposure prophylaxis (PrEP), investigating the comparative effectiveness of Nucleoside Reverse Transcriptase Inhibitors (NRTIs) and Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs) drug regimens in high-risk heterogeneous populations. She has worked at the National Institutes of Health (NIH) for over 10 years, serving in various interdisciplinary scientific positions in NIH’s extramural and intramural biomedical research programs, policy, and review administration. Dr. Paria began her public health career at the National Cancer Institute and subsequently served at the National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Mental Health, and National Institute of Nursing Research. She came to CSR from the National Institute on Aging-Division of Neuroscience where she worked on neuroepidemiology, Alzheimer’s disease (AD), and AD-related dementias (ADRD) research programs. Her research expertise spans multi-level prevention of population, community, and global health, biobehavioral and socio-environmental interventions, and implementation science. As a scientific review officer in CSR, Dr. Paria plans, coordinates, and conducts meetings for a variety of standing and special emphasis panels (SEPs) study sections that review epidemiologic research on diverse award mechanisms for research project grants, HIV-expedited proposals, cooperative research agreements, career development, and fellowships. Prior to joining NIH, she served at the Uniformed Services University and the U.S. Nuclear Regulatory Commission.
Dr. Paria holds Doctor of Health Sciences (D.H.Sc.) from the University of Bridgeport College of Health Sciences, a Master of Science (M.S.) in biotechnology-biodefense from the University of Maryland and a Master of Public Health (M.P.H.) in epidemiology and a Certification in Global Health from the University of Massachusetts.
